If you have been reading about thymosin beta-4 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-11. Where a claim depends on a specific study, the study is described rather than over-claimed.
Long-term storage is generally at minus twenty degrees Celsius or colder, preferably desiccated and protected from light. Lyophilized material is more stable than reconstituted solution, which degrades faster at room temperature. Stability depends on pH, ionic strength, and the presence of oxidising agents. Published stability data for the peptide are limited, so storage claims in catalogues should be treated as general guidance rather than measured guarantees. Freeze-thaw cycles are kept to a minimum.
Identity and purity are normally confirmed by reversed-phase high-performance liquid chromatography and mass spectrometry. The expected mass for the acetylated 28-residue peptide is close to 3108 daltons, and a mass shift indicates a modification or truncation. Peptide mapping after enzymatic digestion can resolve sequence-level questions. Counter-ion content, water content, and residual solvents are separate quality attributes that a certificate of analysis may or may not report. Aggregation is monitored by size-exclusion chromatography when relevant.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20 °C or below | Desiccated, protected from light |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity and identity |
| Common synonyms | Thymalfasin, T alpha 1 | Sequence identical to natural fragment |
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Naja annulata (formerly Boulengerina annulata), commonly known as the banded water cobra or the ringed water cobra, is a species of water cobra native to western and central Africa. The species is one of the two species of water cobra in the world, the other one being the Congo water cobra (Naja christyi).
The dangers of radium were recognized in the early 1920s and first described in 1924 by New York dentist and oral surgeon Theodor Blum (1883-1962). He was particularly aware of the use of radium in the watch industry, where it was used for luminous dials. He published an article on the clinical picture of the so-called radium jaw. He observed this disease in female patients who, as dial painters, came into contact with luminous paint whose composition was similar to Radiomir, a luminous material invented in 1914 consisting of a mixture of zinc sulfide and radium bromide. As they painted, they used their lips to form the tip of the phosphorus-laden brush into the desired pointed shape, and this is how the radioactive radium entered their bodies. In the U.S. and Canada alone, about 4,000 workers were affected over the years. In retrospect, the factory workers were called the Radium Girls. They also played with the paint, painting their fingernails, teeth and faces. This made them glow at night to the surprise of their companions.
== Recognition == 1989 – Award of the Mass Spectrometry Society of Japan 2002 – Nobel Prize in Chemistry 2002 – Order of Culture 2002 – Person of Cultural Merit 2002 – Honorary doctorate from Tohoku University 2003 – Honorary citizenship of Toyama Prefecture 2003 – Special Award of the Mass Spectrometry Society of Japan 2006 – Member of Japan Academy 2024 – IEEE Milestone for "LAMS-50K" (one of the 5-member development team)
Sources: en.wikipedia.org
=== Skin === Human skin has a limited capacity for regeneration, and wound healing therefore typically results in scar formation. In contrast, fetal skin is capable of healing without scarring, a phenomenon that has prompted research into the mechanisms underlying scarless healing and their potential application to regenerative therapies in adults.
== Types of natural molecules present in wine == Acids in wine Phenolic compounds in wine Proteins in wine Sugars in wine Yeast assimilable nitrogen Minerals Dissolved gas (CO2) Monoterpenes and sesquiterpenes such as linalool and α-terpineol Glutathione (reduced and oxidized)
=== Bones === Studies have shown that a (non-lacto) vegetarian diet may increase the risk of calcium deficiency and low bone mineral density. A 2019 review found that vegetarians have lower bone mineral density at the femoral neck and lumbar spine compared to omnivores. A 2020 meta-analysis found that infants fed a lacto-vegetarian diet exhibited normal growth and development. A 2021 review found no differences in growth between vegetarian and meat-eating children. A 2025 systematic review and meta-analysis of 59 studies covering 48,626 children and adolescents found that well-planned lacto-ovo-vegetarian and vegan diets can support healthy growth and were associated with improved cardiovascular risk markers, but carried a higher risk of shortfalls in vitamin B12, vitamin D, calcium, iron, and zinc when not addressed through fortified foods or supplements.
=== China === In China, Pizza Hut (simplified Chinese: 必胜客; traditional Chinese: 必勝客; pinyin: Bìshèng Kè) used an altered business model, offering a fine-dining atmosphere with knives and forks and using an expanded menu catering to Chinese tastes. Its first location in the Chinese market opened in Beijing in 1990. By 2008, Pizza Hut operated restaurants and delivery locations. That year, the company introduced "Pizza Hut Express", opening locations in Shanghai, Shenzhen, and Hangzhou. The 160 restaurants were in 40 Chinese cities in 2005. As of 2015, Pizza Hut had 1,903 restaurants in China. By June 2023, there were 3,000 stores. As of the end of September 2025, Pizza Hut has over 4,000 outlets in over 1,000 cities. Savio S. Chan (陳少宏, Pinyin: Chén Shàohóng) and Michael Zakkour, authors of China's Super Consumers: What 1 Billion Customers Want and How to Sell it to Them, stated middle-class Chinese perceive Pizza Hut as "akin to fine dining", though Pizza Hut was "China's largest and most successful foreign casual-dining chain".
Sources: en.wikipedia.org
Lyophilized powder is normally kept at minus twenty degrees Celsius or below, in a sealed container, desiccated and away from light. Reconstituted solutions are less stable and are usually refrigerated and used quickly. Repeated temperature cycling should be avoided.
Mass spectrometry gives the molecular mass, which is compared with the calculated value. Reversed-phase liquid chromatography shows purity and the presence of related impurities. Peptide mapping can verify the amino acid sequence when a higher level of detail is needed.
It reports the tests the supplier performed, which may vary between laboratories and lots. Methods and acceptance criteria are not standardised across suppliers. Buyers often request the actual chromatograms and spectra rather than a summary statement.
It corresponds to the first 28 amino acids of thymosin beta-4, a larger protein found in many tissues. The fragment is acetylated at its N-terminus and is produced synthetically for research and pharmaceutical use. Synthetic and natural forms share the same sequence.